Work

Pembrolizumab (Pembro) plus enzalutamide (Enz) in metastatic castration resistant prostate cancer (mCRPC): Extended follow up.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.5047

Authors: Julie Nicole Graff, Joshi J. Alumkal, Reid F. Thompson, Amy Moran, George V. Thomas, Mary A Wood, Charles G. Drake, Rachel Slottke, Tomasz M. Beer

Institutions: Oregon Health & Science University, VA Portland Health Care System, OHSU Knight Cancer Institute, University of Pennsylvania, Herbert Irving Comprehensive Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2883285168

Cites:

Cited by: 34

Related to: 10